The Peptide Podcast

By: The Peptide Queen
Listen for free

  • Summary

  • The Peptide Podcast is on a mission to help people enjoy making decisions about their health and wellness. Staying informed with our SIMPLE, FAST, FUN approach. We keep you up-to-date on everything peptides. From disease management and prevention to performance health, anti-aging strategies, and more. We give you accurate, unbiased information so you can choose the peptides that suit YOU best. In our casual and easy-to-understand style, we’ll help you save time and energy for what matters most. About the host: Our experienced clinical pharmacist, The Peptide Queen, knows all too well that the internet is flawed, confusing, and hard to navigate. She has over 14 years of experience in retail, hospital, and specialty pharmacy, with certifications in peptide therapy, international travel medicine, immunization delivery, and pharmacogenomics. She’s passionate about helping you stay informed, save time, and feel less overwhelmed by the amount of information (or misinformation) on the internet.
    This website and its content are copyright of The Peptide Podcast - All rights reserved. Any redistribution or reproduction of part or all of the contents in any form is prohibited.
    Show More Show Less
Alternative & Complementary Medicine Exercise & Fitness Hygiene & Healthy Living
Show More Show Less
activate_samplebutton_t1
Episodes
  • Tirzepatide for the Treatment of Obstructive Sleep Apnea

    Tirzepatide for the Treatment of Obstructive Sleep Apnea
    Oct 3 2024

    Imagine waking up refreshed after a full night’s sleep, free from the constant interruptions of obstructive sleep apnea (OSA). Now, imagine treating your OSA without relying on a bulky CPAP machine but with a convenient once-weekly injectable medication instead. Enter tirzepatide, the breakthrough peptide originally designed for diabetes and weight loss, is now making waves in treating OSA.

    Recent studies reveal that tirzepatide (Mounjaro, Zepbound) reduces apnea episodes and promotes significant weight loss, tackling one of the root causes of sleep apnea.

    In this podcast, we’ll talk about the science behind this exciting new study.

    Tirzepatide is a dual agonist that acts like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). GLP-1 and GIP are hormones naturally produced in the gut.

    These hormones are important in regulating blood sugar levels, insulin secretion, and appetite control, which is why tirzepatide was first developed for type 2 diabetes and obesity management. By mimicking these hormones, tirzepatide enhances insulin sensitivity, reduces glucagon levels, and slows gastric emptying, which collectively aids in appetite suppression and promotes significant weight loss.

    The connection between tirzepatide and obstructive sleep apnea (OSA) lies in its ability to reduce body weight. OSA is often exacerbated by excess fat around the neck and airway, which leads to airway obstruction during sleep.

    Weight loss is one of the most effective non-surgical treatments for OSA because it reduces this physical pressure, allowing the airway to stay open during sleep. By helping patients lose a substantial amount of weight, tirzepatide can reduce the severity of OSA symptoms.

    The latest publication from the New England Journal of Medicine (NEJM) discusses the impact of tirzepatide on obstructive sleep apnea (OSA) in individuals with obesity.

    Tirzepatide was tested in the SURMOUNT-OSA trial to determine its effect on OSA. The study showed that tirzepatide significantly reduced the severity of OSA over one year. The primary measurement was the Apnea-Hypopnea Index (AHI), which tracks the number of breathing interruptions per hour during sleep.

    In the trials, participants experienced a reduction in AHI by up to 56% compared to placebo. Additionally, body weight decreased by 16-17%, which is notable since weight loss directly improves OSA symptoms.

    Beyond the improvements in sleep quality, the study also observed benefits like reduced blood pressure, which could have positive cardiovascular implications for patients with OSA. But, further research is needed to determine whether these improvements lead to long-term reductions in cardiovascular events.

    Tirzepatide’s effectiveness in treating OSA provides a promising new avenue for managing the condition, especially for patients who struggle with conventional therapies like CPAP or want to avoid oral facial surgery.

    The full clinical impact of tirzepatide on patient-centered outcomes, such as quality of life and long-term health benefits, is still under investigation. While initial studies show promising improvements in sleep apnea severity and weight loss, more research is needed to fully understand its effects on broader health markers and long-term outcomes.

    Additional trials will determine whether these short-term benefits translate into sustained improvements in overall health, quality of life, and reduced risks of associated conditions such as cardiovascular disease​.

    Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!

    We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.

    Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
    Show More Show Less
    4 mins
  • FAQs About Tirzepatide

    FAQs About Tirzepatide
    Sep 26 2024
    Curious about how tirzepatide can help with weight loss? From understanding how it works to managing potential side effects, many have questions about this medication. In this podcast, we’ll discuss the top questions to give you a clearer picture of how tirzepatide might fit into your weight loss journey. How does tirzepatide work for weight loss?Tirzepatide, marketed as Zepbound, mimics the action of GLP-1 and GIP, two hormones naturally released by your gut. These hormones are critical in regulating appetite and how much food you consume. By enhancing the feeling of fullness and reducing hunger, tirzepatide helps support weight loss. Specifically, it has the following effects: Slows stomach emptying, helping you feel full longer after meals. Decreases appetite, leading to reduced food intake. Reduces food cravings. Stimulates the pancreas to release more insulin, which lowers blood sugar levels. Reduces the liver’s new glucose production, further improving blood sugar control. These combined effects make tirzepatide a powerful tool for weight management and improving metabolic health. 1. How long does it take for tirzepatide to work? In clinical trials, people typically began to notice weight loss around 4 weeks after starting tirzepatide. This is when the medication reaches stable levels in the body. The trial lasted for 72 weeks, and the participants continued to lose weight throughout the study. However, the most significant results were observed during the first 8 to 9 months of treatment. 2. How much weight do people lose with tirzepatide? Tirzepatide is one of the most effective weight-loss treatments available. In clinical trials, people lost, on average, between 15% and 21% of their starting body weight after 72 weeks of treatment. Additionally, longer treatment with tirzepatide tends to lead to more significant weight loss. People in two different studies lost an average of 25% of their starting body weight when using tirzepatide for an extended period. 3. What’s the typical tirzepatide dosage for weight loss? The initial tirzepatide dosage is 2.5 mg once a week for the first 4 weeks. After that, the dose is increased to 5 mg weekly. Most people remain on the 5 mg dose for the long term. If necessary, the dose can be gradually increased. But the increases should be by no more than 2.5 mg at a time, and there should be at least 4 weeks in between each one. The maximum tirzepatide dose is 15mg weekly. 4. How long does tirzepatide stay in your system? Tirzepatide has a half-life of about 5 days, meaning that it takes this amount of time for your body to eliminate half of the medication. This helps determine when a medication starts wearing off and influences its dosing schedule. Since Tirzepatide’s half-life is 5 days, it only needs to be injected once weekly. On the other hand, a longer half-life means it takes more time for your body to fully eliminate a medication. In the case of tirzepatide, small amounts of the medication may remain in your system for up to 25 days after a dose. 5. How long do you need to take tirzepatide? The duration of tirzepatide treatment depends on your health and weight loss goals. It’s best to work with your healthcare provider to determine a timeline that suits your needs. Keep in mind that tirzepatide is designed for long-term use. Still, it may only be needed temporarily if you're able to adopt and sustain certain lifestyle changes after discontinuing the medication . Research shows that maintaining weight loss with tirzepatide is achievable with continued use. At the end of clinical trials, nearly 90% of participants maintained at least 80% of the weight they lost during the first 8 to 9 months. If you plan to stop taking tirzepatide, it’s important to work with your healthcare provider to develop a strategy to help maintain your weight loss. They can help create a plan to continue important lifestyle changes such as proper nutrition, regular physical activity, stress management, and quality sleep. 6. Can you change your tirzepatide injection day? Yes, you can adjust your tirzepatide injection day if needed (e.g., illness, vacation, side effects), but there are specific guidelines to follow. When switching injection days, make sure there’s at least a 3-day (72-hour) gap between two doses. For instance, if you typically inject on Saturdays, you could move it to Tuesday (or another later day in the same week). It's important to consult your healthcare provider before making this change. They can give you a safe and appropriate schedule based on your circumstances. 7. Can you switch from semaglutide to tirzepatide? Yes, you can switch from semaglutide to tirzepatide if you need additional support with weight management. Based on your current semaglutide dosage and any side effects you're experiencing, your healthcare provider may begin you on a lower dose of tirzepatide. This approach allows your body to adjust to tirzepatide ...
    Show More Show Less
    9 mins
  • SS-31

    SS-31
    Sep 19 2024
    What is SS-31? Ela-mep-ra-tide SS-31, also known as Elamipretide, is a synthetic peptide that has gained attention in the scientific and medical communities for its potential role in treating various age-related and degenerative diseases. It is a small, mitochondria-targeting peptide specifically designed to protect and improve the function of mitochondria, the energy-producing "powerhouses" of our cells. Since mitochondrial dysfunction is linked to many chronic illnesses and the aging process, SS-31 has sparked interest in its potential to restore cellular energy and combat diseases at the cellular level. In this podcast, we’ll discuss how SS-31 works and its potential benefits. How Does SS-31 Work? Mitochondria are essential for producing energy in cells through a process known as oxidative phosphorylation. During this process, mitochondria generate ATP, the primary energy source for most cellular functions. However, as we age or develop certain diseases, mitochondria can become less efficient, leading to oxidative stress and damage to cellular structures. This damage can result in various health issues, from muscle weakness to neurodegenerative diseases. SS-31 directly interacts with cardiolipin, a key phospholipid in the inner mitochondrial membrane. Cardiolipin plays an essential role in maintaining mitochondrial structure and function. When mitochondria are stressed or damaged, cardiolipin can become dysfunctional. SS-31 binds to cardiolipin and helps stabilize it, protecting mitochondria from further damage. This stabilization improves mitochondrial efficiency, reduces oxidative stress, and enhances energy production. Additionally, SS-31 helps reduce the production of reactive oxygen species (ROS), harmful molecules that can contribute to inflammation and cellular damage. By reducing oxidative stress, SS-31 may help prevent further damage to tissues and cells, slowing the progression of disease and the aging process. Potential Benefits of SS-31 Research on SS-31 is still in the early stages, but some potential benefits of this peptide have been identified, particularly in the context of mitochondrial health and age-related diseases. 1. Improved Muscle Function SS-31 has been shown to enhance muscle function, particularly in older adults or those with muscle-related diseases. By improving mitochondrial efficiency, SS-31 may help increase muscle strength and endurance, potentially benefiting conditions like sarcopenia (age-related muscle loss) and muscular dystrophies. 2. Neuroprotection Since mitochondrial dysfunction is linked to neurodegenerative diseases such as Alzheimer's and Parkinson's, SS-31’s ability to stabilize mitochondria may offer neuroprotective effects. Early research suggests that SS-31 may help protect brain cells from oxidative damage and reduce inflammation, which could slow the progression of neurodegenerative diseases. 3. Cardiovascular Health SS-31 may also have potential benefits for heart health. By protecting mitochondria in cardiac cells, SS-31 could help prevent damage to the heart and improve its function. Some studies have explored its role in treating conditions like heart failure and ischemia-reperfusion injury, where mitochondrial dysfunction plays a significant role. 4. Anti-Aging Properties Because mitochondrial damage is closely associated with aging, SS-31 may have anti-aging benefits. By improving mitochondrial function and reducing oxidative stress, SS-31 could help slow the aging process at the cellular level, promoting healthier aging and potentially extending lifespan. 5. Treatment of Metabolic Disorders There is growing interest in SS-31’s potential to treat metabolic disorders such as diabetes. Mitochondrial dysfunction is linked to insulin resistance, and improving mitochondrial function with SS-31 could enhance glucose metabolism and insulin sensitivity. 6. Increased energy levels SS-31 peptide boosts energy by targeting and protecting mitochondria, the "powerhouses" of your cells. Mitochondria generate ATP, the main energy source for cellular functions. As we age or experience stress, mitochondrial efficiency declines, leading to fatigue and reduced cellular energy. SS-31 works by stabilizing the mitochondria, preventing oxidative damage, and improving ATP production. This results in increased cellular efficiency, allowing you to feel more energized. It's like upgrading an old car engine—it runs smoother, more efficiently, and with less strain, giving you more stamina throughout the day. What to listen to next: To learn more about how other peptides can help with neurodegenerative diseases, listen to our podcast discussing the potential use of GLP-1 agonists in Alzheimer’s disease and how they work or DIHEXA and cognitive health. To learn more about how other peptides can help heart health, listen to our podcast about GLP-1 agonists in the context of post-MI management. Thanks again for listening to The Peptide Podcast. We love ...
    Show More Show Less
    5 mins

What listeners say about The Peptide Podcast

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.